Adtalem Global Education (NYSE:CVSA) CFO Sells $295,437.90 in Stock

Adtalem Global Education Inc. (NYSE:CVSA) CFO Robert Phelan sold 2,186 shares of the firm’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of $135.15, for a total transaction of $295,437.90. Following the transaction, the chief financial officer directly owned 48,306 shares of the company’s stock, valued at approximately $6,528,555.90. This represents a 4.33% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Performance

CVSA opened at $132.20 on Friday. The company has a market cap of $4.50 billion, a P/E ratio of 18.78, a P/E/G ratio of 0.95 and a beta of 0.62. The business has a 50-day moving average of $125.16. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.09 and a quick ratio of 1.09. Adtalem Global Education Inc. has a 1-year low of $86.97 and a 1-year high of $156.26.

Adtalem Global Education (NYSE:CVSA) last issued its quarterly earnings results on Thursday, August 6th. The company reported $2.09 EPS for the quarter, topping the consensus estimate of $1.90 by $0.19. The business had revenue of $501.38 million for the quarter. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, sell-side analysts expect that Adtalem Global Education Inc. will post 8.99 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Adtalem Global Education

An institutional investor recently bought a new position in Adtalem Global Education stock. Kendall Capital Management bought a new position in Adtalem Global Education Inc. (NYSE:CVSA) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 11,622 shares of the company’s stock, valued at approximately $1,449,000. Institutional investors own 98.84% of the company’s stock.

Analysts Set New Price Targets

CVSA has been the subject of several research reports. Barrington Research reiterated an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a research report on Monday, June 8th. Truist Financial boosted their price target on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, May 11th. Weiss Ratings reissued a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Friday, May 22nd. Finally, Wall Street Zen upgraded Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.